Fórmulas para nutrição enteral padrão e modificada disponíveis no Brasil: levantamento e classificação
Introduction: Enteral Nutritional Therapy is of great importance in the treatment of individuals who for some reason cannot adequately feed themselves orally. There are in the Brazilian market different types of industrialized enteral formulas and legislations that govern their characteristics, comp...
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2018 |
| País: | Brasil |
| Institución: | Universidade Federal de Minas Gerais (UFMG) |
| Repositorio: | Repositório Institucional da UFMG |
| Idioma: | portugués |
| OAI Identifier: | oai:repositorio.ufmg.br:1843/39498 |
| Acceso en línea: | http://hdl.handle.net/1843/39498 |
| Access Level: | acceso abierto |
| Palabra clave: | Nutrição enteral Terapia nutricional Alimentos formulados Brasil |
| Sumario: | Introduction: Enteral Nutritional Therapy is of great importance in the treatment of individuals who for some reason cannot adequately feed themselves orally. There are in the Brazilian market different types of industrialized enteral formulas and legislations that govern their characteristics, composition and classification. This article aims to tabulate the enteral formulations existing in Brazil today, describing them and classifying them according to the current legislation. Methods: The proposal included tabulation of nutritional information from standard enteral diets with and without fiber and specific modified diets for diabetics, liverworts, nephropathies, pneumopathies, with immunomodulators, hydrolyzed and for healing of pressure ulcers. The respective classifications and prices were also included in order to facilitate selection in nutritional treatments. Results: A total of 74 formulas were collected from six different laboratories: 24.3% were standard formulas without fibers, 22.9% were standard with fibers, 13.5% were diabetics, 5.4% were hepatopathies, 8.1% were nephropathies, 4.1% for pneumopathies, 4.1% with immunomodulators, 13.5% hydrolysates and 4.1% for healing. Conclusions: The formulas have different characteristics regarding composition, which also justifies the wide variation of prices. In addition to cost-benefit, the choice should be made based on their composition, according to the individual nutritional needs of the patient, in order to select a formula that potentiates the response and increase the chances of success in nutritional therapy. |
|---|